IDIBELL facilitates and promotes the transfer of the knowledge generated by its researchers through clinical trials, patents, codevelopment agreements or the creation of spin-off companies. Since 2020, priorities included adding more value to the portfolio and designing new strategies for internationalization to become more competitive worldwide.